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The proteins responsible for controlling electron transfer in bacterial secondary metabolism are not always
known or characterised. Here we demonstrate that many bacteria contain a set of unfamiliar ferredoxin
encoding genes which are associated with those of cytochrome P450 (CYP) monooxygenases and as
such are involved in anabolic and catabolic metabolism. The model organism Mycobacterium
marinum M contains eleven of these genes which encode [3Fe–4S] or [4Fe–4S] single cluster containing
ferredoxins but which have unusual iron–sulfur cluster binding motif sequences, CXX?XXC(X)nCP, where
‘?’ indicates a variable amino acid residue. Rather than a cysteine residue, which is highly conserved in
[4Fe–4S] clusters, or alanine or glycine residues, which are common in [3Fe–4S] ferredoxins, these
genes encode at this position histidine, asparagine, tyrosine, serine, threonine or phenylalanine. We have
puriﬁed, characterised and reconstituted the activity of several of these CYP/electron transfer partner
systems and show that all those examined contain a [3Fe–4S] cluster. Furthermore, the ferredoxin used
and the identity of the variable motif residue in these proteins aﬀects the functionality of the
monooxygenase system and has a signiﬁcant inﬂuence on the redox properties of the ferredoxins.
Similar ferredoxin encoding genes were identiﬁed across Mycobacterium species, including in the
pathogenic M. tuberculosis and M. ulcerans, as well as in a wide range of other bacteria such as
Rhodococcus and Streptomyces. In the majority of instances these are associated with CYP genes.
These ferredoxin systems are important in controlling electron transfer across bacterial secondary
metabolite production processes which include antibiotic and pigment formation among others.Introduction
Electron transfer is fundamental for all living organisms,
being involved in respiratory processes to produce chemical
energy within the cell, pathways to build large molecules
from smaller substrates (anabolic) and the breakdown of
molecules into smaller species for cellular metabolism
(catabolic). The electron carrier proteins involved in these
pathways tightly regulate the shuttling of electrons between
the donor and acceptor.1,2 Monooxygenases are an essential
set of enzymes that are intrinsically involved in theseaide, SA 5005, Australia. E-mail: stephen.
mistry, School of Chemistry, University of
h, NR4 7TJ, UK
f Essex, Wivenhoe Park, Colchester CO4
(ESI) available: Details of M. marinum
ditional data tables and gures. See
mistry, Vanderbilt University School of
6, USA.
Chemistry 2018anabolic and catabolic processes and require a supply of
electrons in order to function. They typically catalyse the
selective hydroxylation of a wide range of organic molecules
using dioxygen (eqn (1)).3,4
R–H + 2H+ + 2e + O2/ R–OH + H2O (1)
In Nature, monooxygenase enzymes, including cytochrome
P450 enzymes (CYP), show exquisite selectivity. The bacterial
CYP family has a broad substrate spectrum yet each individual
enzyme can be highly specic. For these reasons many bacteria,
including Mycobacteria, have a large and highly evolved CYP
complement (CYPome) which functions to break down or syn-
thesise molecules as required by the organism.5 These enzymes
are a valuable resource for biocatalysis and key targets for
antibacterial drug design.6–8
The two electrons required by CYP enzymes are usually
derived from NAD(P)H and delivered by electron transfer
proteins in two distinct steps. Bacterial CYP enzymes typically
use Class I electron transfer systems which normally consist of
a NAD(P)H-dependent ferredoxin reductase (FdR) and an iron–
sulfur ferredoxin (Fdx).9 The reductase most oen contains anChem. Sci.
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View Article OnlineFAD cofactor. The best studied ferredoxins in these systems are
[2Fe–2S] types but [3Fe–4S], [4Fe–4S] clusters, combinations
thereof and exceptions such as the FMN containing cindoxin
and self-suﬃcient P450Bm3 are known.7,9–12 The CYP enzymes
have evolved to be highly specic for their electron transfer
partners from the same species.13 Yet within a given bacterium
the electron transfer systems can support multiple CYP
enzymes and accordingly the number of genes in a bacterium
normally decreases in the order CYP > ferredoxin > ferredoxin
reductase.14–17
One bacterium which contains many of these systems is
Mycobacterium marinum, a ubiquitous pathogen of sh and
amphibians, which can infect humans causing aquarium gran-
uloma.20,21 M. marinum can survive in extracellular environmental
conditions and is used as a model organism to plot the evolu-
tionary pathway of other more specialist Mycobacterium patho-
gens.22 It is closely related to the slower growing human
pathogens Mycobacterium ulcerans (97% nucleotide sequence
identity) and Mycobacterium tuberculosis (85%) which cause Bur-
uli ulcer (Bairnsdale or Daintree ulcer) and tuberculosis, respec-
tively.20–23 Tuberculosis is a global epidemic and a major cause of
human mortality and is a growing problem due to the evolution
of drug resistant strains.24,25 Buruli ulcer is a serious skin disease
prevalent in Africa, Oceania and Asia.26 The mycobacterial path-
ogens that cause these more serious conditions have adapted to
the specic host environment inwhich they are found and are not
viable in other settings. In comparison to M. marinum, both M.
tuberculosis and M. ulcerans have undergone reductive evolution.
This occurred via genome downsizing and pseudogene forma-
tion, through the introduction of mutations or insertion
sequences.27–29 Another human pathogen, Mycobacterium leprae,
responsible for leprosy, has undergone extreme reductive evolu-
tion and contains less than half the number of genes of M.
tuberculosis. In addition these bacteria have also acquired certain
unique genes which encode proteins critical to their survival.23,29
Here we report that there are substantiallymore CYP encoding
genes inM. marinum than inM. ulcerans andM. tuberculosis. The
genome of M. marinum also contains many genes which encode
atypical ferredoxins. Most of these are located close to CYP genes
and the majority are [3/4Fe–4S] type ferredoxins containing
unusual residues in the iron–sulfur cluster bindingmotif. Rather
than having the CXXCXXC(X)nCP motif of a [4Fe–4S] cluster
ferredoxin or the CXXA/GXXC(X)nCP motif of a [3Fe–4S] cluster
ferredoxin, a diﬀerent amino acid such as histidine replaces the
second cysteine of the [4Fe–4S] motif or the glycine/alanine
residue in the [3Fe–4S] ferredoxin motif (CXXHXXC(X)nCP).18
Themajority of these have yet to be studied and characterised.18,19
By searching for similar electron transfer systems we nd
that other residues are commonly located at this position (CXX?
XXC(X)nCP) in ferredoxins of this type, from other
bacteria.15,30–34 For example, the ferredoxin genes ofM. marinum
encode proteins which contain histidine, asparagine, serine,
threonine, tyrosine and phenylalanine. We identify that these
types of ferredoxin genes are prevalent across many other
bacterial species and isolate and characterise several of the M.
marinum suite. We demonstrate that, in combination with the
same ferredoxin reductase, they can support theChem. Sci.monooxygenase activity of their associated CYP enzymes. We
characterise the cluster type and importance of the variable
residue by a variety of methods and show that they signicantly
alter the properties of the iron–sulfur cluster. We also demon-
strate that CYP enzyme activity is dependent on choosing the
correct ferredoxin. Therefore the ferredoxins which contain
these unusual residues have a critical function in the metabo-
lism ofM. marinum and other bacteria through their support of
electron transfer to monooxygenase systems.
Results
Analysis of the CYPome and the potential electron transfer
partners of M. marinum
There are forty seven CYP enzyme encoding genes inM. marinum
and these belong to thirty six diﬀerent P450 families and thirty
nine subfamilies (see ESI for further details; Tables S1, S2 and
Fig. S1†). Comparatively there are only twenty CYP enzymes inM.
tuberculosis and twenty four in M. ulcerans. In contrast to these
species, M. leprae contains only one CYP enzyme encoding gene,
CYP164A1. This follows from the smaller gene complement of
these bacteria due to reductive evolution (Tables S1 and S3†).35–37
The CYPome of M. marinum plays a role in the bacterium's
anabolic and catabolic metabolism. The substrate proles of
several of the cytochrome P450 enzymes can be inferred from
sequence homology to those that have been previously studied in
other mycobacterial species and inferred from sequence
homology (see ESI†).38–43
There are many ferredoxin genes associated with the
CYPome of M. marinum. Overall M. marinum contains a set of
eleven genes encoding ferredoxins of the single iron–sulfur
cluster [3/4Fe–4S] type (Fdx1–Fdx11). These contain the motif
CXX?XXC(X)nCP without a cysteine at the ‘?’ position (Fig. 1,
S2†). These include the equivalent ferredoxins to Rv0763 and
Rv1786 of M. tuberculosis, (Fdx1 and Fdx10 in M. marinum;
CXXHXXC(X)nCP, Table 1). These are the only electron transfer
partner genes from the CYPome of M. tuberculosis (ferredoxin
and ferredoxin-NAD(P)H reductase-like proteins) located in the
vicinity of the CYP genes (Tables S4 and S5†).5,30,44–46 In both
Mycobacterium species these two ferredoxins are located next to
the genes of CYP51 and CYP143 (Tables 1, S3, Fig. S3†).
Equivalent genes to all of the electron transfer partners of M.
tuberculosis are also present in the genome of M. marinum
(Table S5†). The ferredoxins, Fdx5 and Fdx8, from M. marinum,
also contain a histidine residue at the variable position.
The gene for the CYP153A16 enzyme (Mmar_3154) is in
a cluster with genes encoding a [2Fe–2S] ferredoxin (Mmar_3155)
and a ferredoxin reductase (FdR2, Mmar_3153), which completes
a class I electron transfer system in M. marinum (FdR2/[2Fe–2S]
ferredoxin/CYP153A16).43 A second gene encoding the CYP147G1
(Mmar_2930) enzyme is in a cluster with genes encoding
a ferredoxin reductase (FdR1, Mmar_2931) and a ferredoxin
(Fdx3, Mmar_2932). There are therefore two obvious complete
electron transfer systems in M. marinum (FdR1/Fdx3/CYP147G1
and FdR2/[2Fe–2S] ferredoxin/CYP153A16). By analogy with
other bacterial systems these two ferredoxin reductases are likely
to be responsible for the reduction of ferredoxins and thereforeThis journal is © The Royal Society of Chemistry 2018
Fig. 1 The X-ray crystal structure of the histidine containing ferre-
doxins from R. palustris HaA2 (PDB 4ID8).18 (A) Full structure; (B)
a zoomed in view of the iron–sulfur cluster with the residues of the
ferredoxin bindingmotif highlighted. Themotif of the ferredoxins from
M. marinum is highlighted. These residues would replace the histidine
which is highlighted in the ﬁgure.
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View Article Onlinesupport the CYP enzymes in M. marinum.11,13,47,48 Fdx3, has
a tyrosine in its cluster binding motif (CXXYXXC(X)nCP). The
other ferredoxins of M. marinum contain asparagine (Fdx4, Fdx7
and Fdx11), serine (Fdx9), threonine (Fdx2) or phenylalanine
(Fdx6) residues at this position of the cluster binding motifTable 1 The potential electron transfer partners of the CYPome of M. m
the databases at the National Center for Biotechnology Information is pro
4Fe–4S] ferredoxins as well as the predicted pI and length of the amino a
and M. tuberculosis are given. The neighbouring CYP genes (1–4 genes
Gene name ID
Iron–sulfur
cluster binding motif pI
Mmar_2667 Fdx1 CXXHXXC(X)nCP 3.9
Mmar_2879 Fdx2 CXXTXXC(X)nCP 4.0
Mmar_2932 Fdx3 CXXYXXC(X)nCP 4.3
Mmar_3973 Fdx4 CXXNXXC(X)nCP 3.7
Mmar_4716 Fdx5 CXXHXXC(X)nCP 3.7
Mmar_4730 Fdx6 CXXFXXC(X)nCP 4.3
Mmar_4734 Fdx7 CXXNXXC(X)nCP 3.8
Mmar_4736 Fdx8 CXXHXXC(X)nCP 4.0
Mmar_4763 Fdx9 CXXSXXC(X)nCP 3.9
Mmar_4933 Fdx10 CXXHXXC(X)nCP 4.4
Mmar_4991 Fdx11 CXXNXXC(X)nCP 3.9
Mmar_3155 [2Fe–2S] 4.0
Mmar_2931 FdR1 n.a. 5.8
Mmar_3153 FdR2 n.a. 4.9
This journal is © The Royal Society of Chemistry 2018(Fig. 1, Table 1, Fig. S2†). All bar phenylalanine could potentially
act as a ligand to a metal ion in the cluster.
TheM. marinum ferredoxins of this type range in size from 62
to 97 amino acid residues in length and all have predicted pI
values lower than 7.0 (Table 1). Ten of the potential ferredoxins
ofM. marinum, Fdx11 being the exception, are located next to or
close to a CYP gene (one to four genes away, Fig. S3†). Therefore
these ferredoxins are likely electron transfer partners which
deliver reducing equivalents to the CYP enzymes.33
Of these eleven ferredoxin genes, seven are conserved in M.
ulcerans and only three in M. tuberculosis (Table 1 and
Fig. 2).22,24,26 The ferredoxins which are conserved in both M.
marinum and M. ulcerans are very similar or identical showing
97–100% sequence identity, while those of M. tuberculosis show
more sequence divergence (78–92% identity, Fig. 2). Neither of
the ferredoxin reductase genes (FdR1 and FdR2) are conserved
inM. ulcerans orM. tuberculosis. Extending the search to include
more diverse species of Mycobacteria and other metabolically
varied bacteria revealed the prevalence of analogous ferredoxins
(Tables S6 & S7, Fig. S3†).
With the exception of the threonine containing Fdx2, many
equivalent ferredoxin genes are found across theMycobacterium
genus. These are, more oen than not, located in gene clusters
with associated CYP genes (Table S6, Fig. S3†). They are also
found across other bacteria, including the antibiotic synthe-
sising Streptomyces (where variants in the motif at ‘?’ include
histidine, serine and tyrosine; Table S7†) and Rhodococcus
(where variants in the motif at ‘?’ include histidine, asparagine
and tyrosine; Table S7†).14 They are also associated with the
CYPome of other diverse bacterial species including those of R.
palustris strains (Table S7†).
To provide insight into the important CYP enzyme catalysed
reactions that these ferredoxins support we analysed biosyn-
thetic gene cluster databases for these types of electron transfer
partners (Table S8†). The synthesis of a range of complex
secondary metabolites, including salinomycin, lipin andarinum (which are located close to CYP genes). The gene name as per
vided. The sequence of the iron–sulfur cluster binding motif of the [3/
cid chain are provided. The equivalent ferredoxin genes inM. ulcerans
away) are also shown (Table S1)
AA M. ul M. tb CYP enzyme
63 Mul_5 Rv1786 CYP143A4
63 Mul_4 — CYP278A1
70 — — CYP147G1
62 Mul_6 — CYP269A1 & CYP138A4
65 Mul_1 — CYP188A3
97 — — CYP190A3
62 — — CYP190A3 & CYP150A5
61 — — CYP150A5
63 Mul_2 — CYP105Q4
67 Mul_3 Rv0763 CYP51B1
81 Mul_7 Rv3503c —
105 — — CYP153A16
466 — — CYP147G1
400 — — CYP153A16
Chem. Sci.
Fig. 2 A phylogenetic tree (phenogram) of the [3/4Fe–4S] ferredoxins
from M. marinum (Fdx1–Fdx11), M. ulcerans (Mul_1–Mul_7), and M.
tuberculosis (Rv0763c, Rv1786 and Rv3503c). The ferredoxins from S.
coelicolor, S. lavendulae and the structurally characterised ferredoxins
from R. palustris HaA2, P. furiosus, C. thermoaceticum and T. litoralis
are included for comparison (see ﬁgure). The grouping of the ferre-
doxins fromM. marinum andM. ulcerans show they are closely related
(97–100% sequence identity). There is a lower yet signiﬁcant similarity
to the ferredoxins from M. tuberculosis (78–92% sequence identity;
note the low 78% value is unusual and arises as the gene Rv3503c is
shorter than Fdx11 by the equivalent of nineteen amino acids). For the
majority of the ferredoxins there is a low similarity to those from other
bacterial species, for example Fdx1 has only 35% sequence identity
with the structurally characterised R. palustris HaA2 ferredoxin (PDB:
4ID8). The threonine containing Fdx2 has the closest relationship with
the [3Fe–4S] ferredoxins from Streptomyces species while the [4Fe–
4S] ferredoxins from the thermophiles P. furiosus, C. thermoaceticum
and T. litoralis cluster together.11,14,49–51
Chemical Science Edge Article
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View Article Onlinecinnabaramide, was found to be supported by these CYP
enzyme and ferredoxin combinations. These were mainly found
in strains of Streptomyces bacteria (Table S8†). This gives a small
snapshot of the widespread and critical role these types of
ferredoxins have in bacterial metabolism.Reconstitution of the activity of CYP147G1 using FdR1 and
Fdx3
We set to out to determine whether these electron transfer
partners could support the P450 enzymes of M. marinum and if
the activity would be dependent on using the physiological
ferredoxin electron transfer partners. Fdx3 (Mmar_2932) is the
only ferredoxin of this type from M. marinum to have bothChem. Sci.a reductase gene (FdR1, Mmar_2931) as well as a CYP gene
(CYP147G1, Mmar_2930) co-located in the genome and this was
an obvious system to start with (Table S9†).
In order to assess if the ferredoxin reductase (FdR1) and
ferredoxin (Fdx3) electron transfer proteins could support the
activity of the CYP147G1 enzyme, we constructed a whole-cell
oxidation system.33,52 The FdR1 and Fdx3 genes were cloned in
pETDuet to generate pETDuetFdx3/FdR1 and the CYP147G1
and Fdx3 genes were combined with pRSFDuet to construct
pRSFDuetFdx3/CYP147G1. By transforming both vectors into
E. coli we were able to produce all three proteins together and
support substrate turnover by CYP147G1 utilising intracel-
lular NAD(P)H. When the cells were grown and protein
produced, the culture media took on a blue colouration
indicating that indole generated in the growth media from
tryptophan breakdown was being oxidised to indigo
(Fig. S4†).53 By adding indole to the growth we were able to
generate more indigo (Fig. S4†). When CYP147G1 was
produced in E. coli in the absence of FdR1 and Fdx3 no indigo
formation was observed, suggesting that the two electron
transfer partners from M. marinum are required to support
CYP147G1 activity. The CYP147G1 enzyme was produced in E.
coli and puried by two ion exchange chromatography steps.
Aer purication, CYP147G1 was tested for the characteristic
absorbance of a P450, the Soret absorbance (Fig. S5†). The
binding of CO to the reduced ferrous form of the heme centre
results in the almost complete shi of the Soret peak to
450 nm (95%), indicating the viability of the CYP147G1
enzyme.54
Investigation of the substrate range of the puried
CYP147G1 enzyme was undertaken by UV/Vis analysis of the
spin state of the heme iron.55 Undecanoic acid resulted in the
largest spin state shi (40% high-spin, compared to indole,
<5%) and the dissociation constant was determined to be 25 4
mM (Fig. S6†). These results indicated that undecanoic acid is
complementary to the active site of CYP147G1 and this
substrate was chosen for product formation studies.
Despite multiple attempts, purication of the electron
transfer partners, Fdx3 and FdR1, in a soluble form have not
been successful. The yield of both proteins aer cell lysis was
insuﬃcient for further workup or detailed in vitro analysis of
activity. As Fdx3 and FdR1 are required for the creation of
a native-like electron transfer system in vitro it was necessary to
use whole-cell oxidation systems to investigate product forma-
tion. Undecanoic acid was chosen as a substrate and aer
extraction and derivatisation with N,O-bis(trimethylsilyl)
triuoroacetamide/trimethylsilylchloride (BSTFA/TCMS), the
turnovers were analysed via GC-MS (Fig. S7†). The CYP147G1
turnover of undecanoic acid showed one peak in addition to
that of the substrate. Analysis of the mass spectrum fragmen-
tation pattern for the hydroxyundecanoic acid products dis-
played an increase in the base peak at 117.1 m/z (Fig. S7†). This
is consistent with cleavage next to the CHOSiMe3 group on the
u-1 carbon (forming a CH3CHOSiMe3
+ fragment). NMR analysis
conrmed the product of undecanoic acid turnover was the u-1
hydroxylated acid (10-hydroxyundecanoic acid) from several
diagnostic signals (Fig. S7†).This journal is © The Royal Society of Chemistry 2018
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View Article OnlineThe selectivity of CYP147G1 for Fdx3 and FdR1
In order to investigate the role of Fdx3 in transferring electrons
to CYP147G1, and the importance of the tyrosine residue of its
iron–sulfur cluster binging motif, we tested the turnover activity
of the system by replacing Fdx3 with mutant forms of the
protein and other ferredoxins. Mutant versions of the Fdx3 gene
were generated in which the polar aromatic tyrosine was
replaced with glycine or cysteine. These two mutations were
chosen to mimic the iron–sulfur cluster binding motifs of
a [3Fe–4S] and a [4Fe–4S] ferredoxin, respectively (Fig. S8†). The
mutant ferredoxin enzymes were cloned into both plasmids of
the whole-cell oxidation system, pETDuetFdx3/FdR1 and
pRSFDuetFdx3/CYP147G1, and used to test the activity of the
CYP147G1 enzyme coupled with the mutant and WT forms of
the ferredoxin. Samples of the turnovers taken at 4 hours con-
tained the 10-hydroxyundecanoic acid product (Fig. 4). The level
of product formation when coupled with the WT Fdx partner
was almost double that when coupled with either the Y12C or
Y12G ferredoxins. Both mutant ferredoxins performed similarly
(Fig. 4). Experiments with indole conrmed these results
(Fig. S4†). These results show that the tyrosine amino acid in the
ferredoxin binding sequence is important for the regulation of
electron transfer to the CYP147G1 enzyme or for the stability of
Fdx3.
Next we tested replacing Fdx3/FdR1 electron transfer system
with alternatives. CYP147G1 was cloned into the pRSFDuet
vector by itself and was tested with diﬀerent combinations of
pETDuetFdx(1–11)/FdR1 and the same vector containing alter-
native non-physiological electron transfer partners (see ESI, Fig
S9† for more details). The results from the turnovers of indole
and undecanoic acid were conspicuous, with only the Fdx3
containing system being able to support activity. This was
apparent from both indigo formation in the colorimetric assays
with indole and the generation of 10-hydroxyundecanoic acid in
the GC-MS analysis with undecanoic acid (Fig. S4 and S9†).
None of the other electron transfer systems displayed any
evidence of P450 metabolite formation highlighting the selec-
tivity of CYP147G1 for Fdx3.
Overall, these assays suggest that protein–protein interac-
tions may be more important than the cluster environment for
eﬃcient electron transfer to CYP147G1. The mutation of tyro-
sine to cysteine and glycine would be expected to alter the
properties of the iron–sulfur cluster while maintaining the
protein–protein interactions and the assays with these mutants
displayed signicant activity (albeit reduced compared to the
WT Fdx3). While replacing the ferredoxin with another, would
alter the redox potential it would also change protein–protein
interactions completely and disrupted enzyme activity.Assessing the activity of selected other ferredoxin electron
transfer partners of M. marinum
In order to assess an entire CYP electron transfer chain the
ferredoxin reductase, ferredoxin and CYP enzyme have to be
isolated and the likely substrate for the CYP enzyme has to be
identied. For a bacterium such as M. marinum with so many
potential combinations of CYP enzymes and electron transferThis journal is © The Royal Society of Chemistry 2018partners this would be impractical. We therefore chose pairings
of CYP enzymes and ferredoxins which showed promising levels
of protein production in E. coli and were coupled (in the
genome) to ferredoxin genes. We also chose ferredoxins with
diﬀerent residues at the variable position (?) of the iron–sulfur
cluster motif. Based on the protein production data the
combinations of genomically associated P450 and Fdx genes
chosen were Fdx2(Thr)/CYP278A1, Fdx4(Asn)/CYP269A1,
Fdx8(His)/CYP150A5 and Fdx9(Ser)/CYP105Q4 (Table 1). All
the CYP enzymes were produced in suﬃcient yields enabling
their purication.
CYP105Q4, CYP278A1 and CYP150A5 displayed the expected
substrate-free low spin CYP UV/Vis spectra with a Soret
maximum at 419 nm (Fig. S5†). CYP269A1 was more unusual in
that it had a spectrum that resembled a high spin ferric heme
spectrum with a Soret maximum at 390 nm (Fig. S5†). The
addition of the imidazole antifungal agent miconazole shied
the heme Soret absorbance maximum of CYP269A1 to 423 nm,
and bound with a Kd of 0.050 0.007 mM (Fig. S10†). CYP105Q4,
CYP278A1 and CYP150A5 showed the characteristic shi to
450 nm for the ferrous–CO bound forms. In the absence of
substrate CYP269A1 had a large peak at 420 nm with a shoulder
at 450 nm (Fig. S5†). When miconazole was added the peak at
450 nm increased, indicating the ferrous–CO bound form of the
enzyme, was generated in greater quantity (Fig. S5†).
The addition of b-ionone was found to shi the spin state of
CYP278A1 to the high spin form (50%, Fig. S5†). The binding
aﬃnity of CYP278A1 for b-ionone was also tight; Kd, 5.1  1.5
mM, Fig. S6.†56 Screening a range of aromatic compounds for
their ability to bind to CYP150A5 produced low Type I shis in
the Soret peak absorption (Fig. S6†).57 However, we found that
addition of b-ionone induced a 60% shi to the high spin form
and the binding aﬃnity was also reasonably high; Kd of 41  3
mM (Fig. S6†). None of the extensive range of substrates tested
with CYP105Q4 altered the spin state from the low spin form.
Having identied viable substrates for CYP150A5 and
CYP278A1 and an inhibitor of CYP269A1 we attempted to
produce and purify the associated ferredoxins, Fdx8, Fdx2 and
Fdx4 respectively, as well as Fdx9. The codon optimised genes of
each ferredoxin were obtained and a 6 His tag was added to
the C-terminus by PCR (ESI†). Under aerobic conditions Fdx2
and Fdx9 (associated with CYP278A1 and CYP105Q4, respec-
tively) did not produce signicant levels of folded ferredoxin
aer cell lysis. However Fdx4 and Fdx8 were puried in signif-
icant quantities using an ion exchange step followed by aﬃnity
chromatography (1 mg of puried protein per litre of broth,
Fig. S11†). The UV/Vis spectra of Fdx4 and Fdx8 showed char-
acteristic absorbances of [3/4Fe–4S] cluster containing ferre-
doxins (Fig. 5).18,30
We next used whole-cell oxidation systems to study the
monooxygenase activity of the FdR1/Fdx2/CYP278A1 and FdR1/
Fdx8/CYP150A5 systems. GC and HPLC analysis of the turn-
overs of both systems showed a single product was formed from
b-ionone oxidation. The product eluted at the same retention
time for both systems. Co-elution experiments with turnovers of
b-ionone using the CYP101B1 and P450Bm3 which generate the
3- or 4-hydroxy products, respectively, revealed that the soleChem. Sci.
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View Article Onlineproduct from both CYP278A1 and CYP150A5 systems was 4-
hydroxy-b-ionone (Fig. S12†). This demonstrates FdR1 is able to
support the activities of the Fdx2/CYP278A1 and Fdx8/
CYP150A5 systems as well as Fdx3/CYP147G1 (Fig. 3, 4, S4, S9
and S12†).Fig. 4 CYP147G1 product formation is reduced when supported by
the mutant Fdx partners. (A) GC-MS chromatogram of the CYP147G1
turnover of undecanoic acid (black trace) after derivatisation with
BSTFA/TMSCl. Derivatised undecanoic acid (RT 9.2 min, control red
trace) and the 10-hydroxyundecanoic acid (RT 13.9 min) are shown.
The chromatogram has been oﬀset along the x and y axes for clarity.
(B) Quantitation of the 10-hydroxyundecanoic acid product from
variant Fdx3/CYP147G1 whole-cell turnovers of undecanoic acid. The
axis shows the triplicate average of the area of integrated product peak
divided by the area of the internal standard peak. Error bars show one
standard deviation.Further characterisation of the ferredoxins generated under
anaerobic conditions
The purication of a range of the ferredoxins studied above was
also undertaken under anaerobic conditions to further assess
their redox activity and stability to oxygen. Fdx2 and Fdx3 yiel-
ded very low levels of folded protein making further study
impossible. However, Fdx4 (Asn), Fdx5 (His) and Fdx9 (Ser) were
isolated in good yields (ESI†).
The ferredoxins were characterised by UV/visible absorbance
and CD spectroscopy (Fig. S13†). The UV/visible absorbance
spectra (Fig. S13†) were typical of proteins that contain either
a [3Fe–4S] or [4Fe–4S] cluster. They consisted of a peak at
approximately 430 nm with a larger extinction coeﬃcient when
oxidized than when reduced and showed no evidence of a peak
at 450–460 nm, which is more commonly associated with [2Fe–
2S] centres (Fig. 5 and S13†). As with all Fe–S cluster containing
proteins a number of unresolved, low intensity transitions
combine to produce a broad and generally featureless absor-
bance spectrum in the visible region. Whilst not diagnostic of
cluster type, the bisignate nature of CD spectroscopy oen
aﬀords greater resolution of these spectral components. This
was the case with the spectra of Fdx4, Fdx5 and Fdx9, both as
isolated and incubated with 1.5 mM ascorbate or excess EuCl2 as
reductants or a stoichiometric equivalent of ferricyanide as an
oxidant (Fig. S13†). The CD spectra of each of the ferredoxins in
the oxidized state contained a negative feature at 420 nm
(417 nm in the case of Fdx9) and a positive feature at 470 nm. In
the absorbance spectra the apparent peak at 430 nmmost likely
arises from the scalar sum of the contributions from these two
transitions. Reduction of the cluster results in a blue shi of the
negative feature in the CD spectrum, to 409 nm for Fdx4 with
a concomitant increase in intensity, and to 414 nm for Fdx5
with an apparent decrease in intensity due to overlap with
a positive feature centred at 350 nm. Any shi of the corre-
sponding feature in the spectrum of Fdx9 was less apparent
since full reduction of the cluster could not be achieved with theFig. 3 CYP147G1 oxidation of undecanoic acid to 10-hydrox-
yundecanoic acid by CYP147G1 and the oxidation of b-ionone to 4-
hydroxy-b-ionone by CYP278A1 and CYP150A5.
Fig. 5 The UV/Vis absorbance spectra of aerobically puriﬁed Fdx4
(Fdx3973, black) and Fdx8 (Fdx4736, red) from M. marinum. Other
spectra are included in the ESI.†
Chem. Sci. This journal is © The Royal Society of Chemistry 2018
Fig. 6 CD monitored potentiometric titrations of Fdx4 (Mmar3973,
panel A), Fdx5 (Mmar4716, panel B) and Fdx9 (Mmar4763, panel C).
Traces taken as representing fully oxidized and, where accessible, fully
reduced cluster are shown in bold (for Fdx9 the bold traces corre-
spond to the highest and lowest potentials at which spectra were
recorded). Red arrows in panels A and B indicate the direction of
spectral change upon reduction of the [3Fe–4S] cluster. Panel D
shows the relative proportion of oxidized cluster for Fdx4 (black) and
Fdx5 (blue) as a function of potential. Solid line shows the predicted
behaviour for a single electron oxidation/reduction event with
a midpoint potential of +120 mV vs. SHE (black line) or + 230 mV vs.
SHE (blue line).
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View Article Onlinereductants employed (see below). However, in all cases, CD
spectroscopy aﬀorded a more robust assignment of cluster
oxidation state than the minimal changes observed in the
absorbance spectra.
Fdx4, Fdx5 and Fdx9 were shown to bind a [3Fe–4S] cluster by
a combination of non-denaturing ESI-MS and standard LC-MS
(Fig. S14†). They also exhibited EPR spectra characteristic of
[3Fe–4S] centres (g value 2.03, Fig. S15†) meaning that the
cluster observed by mass spectrometry is unlikely to be the result
of degradation during ionisation.58 A sample of Fdx4 puried by
ion exchange and size exclusion methods had optical properties
identical to those puried exploiting the poly-His tag, demon-
strating that IMAC chromatography does not result in loss of
a loosely bound Fe ion from the cluster. Furthermore, the CD and
absorbance spectra of Fdx4 were unaﬀected by incubation with
ferrous ion (Fig. S16†). We therefore conclude that each of the
ferredoxins binds a [3Fe–4S] cluster following expression in E. coli
and that in vitro incubation with Fe2+ does not lead to incorpo-
ration of a fourth metal ion and reconstitution of a [4Fe–4S]
cluster. The stability of Fdx2 and Fdx4 to oxygenwas also assessed
by UV spectroscopy with no signicant cluster degradation
occurring on exposure to 120 mM O2 for 40 minutes (Fig. S17†).
Attempts to cycle the oxidation state of the clusters bound to
anaerobically puried Fdx4, Fdx5 and Fdx9 were suggestive of
large diﬀerences in their midpoint potentials on variation of the
residue at position ‘?’ in the binding motif. The CD and elec-
tronic absorbance spectra of Fdx4 were altered by incubation
with either a stoichiometric equivalent of K3Fe(CN)6 or excess
EuCl2 as oxidant and reductant, respectively (Fig. S13†). This
suggests a mixed oxidation state of the cluster in the protein
isolated under anaerobic conditions with the cluster being
readily oxidised by K3Fe(CN)6 and reduced by EuCl2. EPR
spectra of the chemically poised samples (Fig S15†) were also
consistent with oxidation and reduction to the EPR active and
EPR silent forms of the cluster, respectively. Equilibration of
Fdx4 with a 1.5 mM solution of sodium ascorbate resulted in
a CD spectrum readily interpreted as a 50 : 50 sum of those of
the oxidised and reduced clusters, suggesting a midpoint
potential closely matched to the ascorbate solution potential
(+60 mV vs. SHE). The optical spectra of Fdx5 were invariant
following incubation with EuCl2 whilst incubation with a stoi-
chiometric equivalent of K3Fe(CN)6 produced signicant
changes that were reversed upon subsequent incubation with
excess EuCl2 (Fig. S13†). Therefore Fdx5 isolated under identical
conditions to Fdx4 contains clusters predominantly in the
reduced state. Incubation of reduced Fdx5 with 1.5 mM sodium
ascorbate had no signicant eﬀect on the CD spectrum indi-
cating that the cluster remained reduced at +60 mV, suggesting
a midpoint potential greater than +150 mV.
In contrast, incubation with K3Fe(CN)6 had no eﬀect on the
optical spectra of Fdx9 whilst EuCl2 led to a reversible loss of CD
intensity demonstrating that the protein was isolated with the
cluster in the oxidised state (Fig. S13†). The EPR spectra of
chemically poised Fdx9 samples indicated that 50% of the
sample retained oxidised clusters following equilibration with
excess EuCl2 (Fig. S15†) suggesting a midpoint potential similar
to that of the Eu3+/Eu2+ couple (360 mV vs. SHE).This journal is © The Royal Society of Chemistry 2018To conrm these observations, experiments were conducted
to more accurately determine the redox potential of the ferre-
doxins. CD monitored titrations of Fdx4, Fdx5 and Fdx9 were
performed in an optical cuvette containing a platinum electrode
under a nitrogen atmosphere (Fig. 6). Samples containing
a mediator cocktail were equilibrated with sodium dithionite or
potassium ferricyanide and used to determine the potential of
the solution (see ESI† for details). For Fdx4 and Fdx5 the spec-
tral response was tted to that predicted by the Nernst equation
for a single electron oxidation/reduction event to yield midpoint
potentials of +120  13 mV for Fdx4 and +230 mV  16 mV for
Fdx5, respectively (Fig. 6). For Fdx9 the CD response became
obscured by absorbance features from added sodium dithionite
before the potential could be lowered suﬃciently to record the
fully reduced spectrum. Whilst this precluded full analysis,
titration to a potential of 308 mV vs. SHE allowed the estimate
of an upper bound to the midpoint potential less than or equal
to 340 mV for this cluster (Fig. 6). These values are in agree-
ment with the observations reported above and highlight that
varying the residue of the motif in each of these ferredoxins
does have a signicant eﬀect on their redox properties.Chem. Sci.
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The CYPome ofM. marinum is larger than that ofM. tuberculosis
and the related M. ulcerans. There are also more electron
transfer partner genes in M. marinum and these are closely
associated with the genes of the CYPome. Given the relative
number of CYP and electron transfer partner genes it is ex-
pected that each electron transfer ferredoxin could support
multiple CYP enzymes. One interesting observation is that Fdx4
is associated with an unusual P450 with substrate free spectra
indicating it exists in the high-spin form.
The majority of the ferredoxins are of the single cluster type
and all have a non-cysteine residue in their iron–sulfur cluster
binding motif, but not an alanine or glycine residue that
commonly replaces the second cysteine of the motif in [3Fe–4S]
ferredoxins. The identity of this residue varies among the
ferredoxins of M. marinum and includes histidine, asparagine,
threonine, tyrosine, serine and phenylalanine. The character of
the non-cysteine residuesmodies the environment of the iron–
sulfur cluster and was shown to eﬀect the properties and
function of the ferredoxin. While many of these non-cysteine
amino acid substitutions have the potential to act as ligands
to metal ions and determine the cluster type ([3Fe–4S] or [4Fe–
4S]) all of the ferredoxins were isolated as [3Fe–4S] forms under
aerobic and anaerobic conditions. With the exception of the
histidine containing version, these types of ferredoxins have not
been characterised previously. The histidine containing ferre-
doxins from Mycobacterium and Rhodopseudomonas species
were isolated aerobically as [3Fe–4S] ferredoxins.18,30–32 By way of
contrast, histidine coordination to [4Fe–4S] iron–sulfur clusters
has been observed in Ni–Fe and Fe-only hydrogenases and in
[2Fe–2S] Rieske proteins.61–63
The most studied ferredoxin of this type is that from the
thermophile Pyrococcus furiosus in which one of the iron ions of
the cluster coordinates to an aspartate residue (CXXDXXC(X)n-
CP).19,59,60 Replacement of the more usual cysteine residue with
aspartate alters the properties of this ferredoxin,most notably the
reduction potential, compared to typical cysteinate-ligated [4Fe–
4S] ferredoxins.51 This ferredoxin is isolated as a [3Fe–4S] ferre-
doxin under aerobic conditions but can be isolated as a [4Fe–4S]
ferredoxin when oxygen is excluded. In common with other
thermophilic ferredoxins, it also contains an additional disul-
phide bond which is thought to take part in the redox cycling of
the enzyme. In contrast to the ferredoxins we have identied, the
redox partner for the aspartate containing ferredoxin from P.
furiosus is as yet unknown. This makes an analysis of the role of
this residue in physiological electron transfer reactions diﬃcult.
The identity of the iron–sulfur cluster, the ligands which
coordinate to the metal ions and the surrounding environment
can have a profound eﬀect on the reduction potential of the
ferredoxins. Cysteine-coordinated [2Fe–2S] containing ferre-
doxins (reduction potential 150 to 400 mV versus SHE) and
the histidine Rieske equivalents (reduction potential +100 to
+400 mV) contain two Fe(III) ions in the oxidised form with one
of these being reduced to Fe(II) in the reduced form.63 It is usual
for [4Fe–4S] clusters to shuttle between the [4Fe–4S]2+/+ stateChem. Sci.and have reduction potentials ranging from 280 to 715 mV,
though high potential iron–sulfur clusters with potentials of
+90 to +450 mV are known ([4Fe–4S]3+/2+).63 Previously charac-
terised [3Fe–4S] ferredoxins have redox potentials ranging from
203 to85 mV.51 The histidine containing [3Fe–4S] ferredoxin
fromM. tuberculosis (31 mV) and the aspartate version from P.
furiosus (160 mV for 3Fe form and375 mV for [4Fe–4S] form)
both have signicantly diﬀerent reduction potentials compared
to standard [3Fe–4S] and [4Fe–4S] ferredoxins. Our results show
that the [3Fe–4S] ferredoxins from M. marinum have reduction
potentials which vary between 340 to +230 mV. Those con-
taining the neutral histidine and asparagine residues, are more
positive compared to other proteins of this type. The serine
containing ferredoxin (Fdx9) had a signicantly lower redox
potential, similar to those of the cysteine containing species. It
seems probable that bacteria may use these diﬀerent motifs to
tune the redox potential in order to facilitate electron transfer to
the diﬀerent monooxygenases present.
The best characterised mycobacterial electron transfer
ferredoxin of this type is encoded by the gene Rv0763c and is
associated with CYP51 of M. tuberculosis.30 This ferredoxin has
been shown to support the rst electron transfer step of CYP51
from M. tuberculosis (but not the monooxygenase activity). The
low activity observed was rationalised by the high reduction
potential of the ferredoxin which is reported to be unfavourable
for the reduction of the substrate bound CYP51. However, it is
important to note that the recognition of the correct electron
transfer partner by the P450 enzyme, through protein–protein
interactions, may have a more important role in determining
the selectivity. This will also contribute to the rate of these steps
of the catalytic cycle. This was highlighted by the strict
requirement of Fdx3 for the reconstitution of the activity of
CYP147G1.
Given that the majority of the types of ferredoxins found in
M. marinum have not been reported previously, we were
surprised to discover that they are prevalent across a range of
bacteria in particular in Mycobacterium, Rhodococcus, Strepto-
myces and other species of actinobacteria. They are also found
in other bacteria. For example, the tyrosine containing ferre-
doxins are found in bacteria of the phylum Chloroexi. Of
particular interest is that bacterial operon predictions (http://
operondb.cbcb.umd.edu) show that the CYP147 genes in
other bacteria including Methanosarcina barkeri (CYP147E1),
Myxococcus xanthus (CYP147A1), M. vanaabelinii (CYP147G2)
and Streptomyces avermitilis (CYP147B1), are all found next to
a ferredoxin reductase encoding gene. All of these also have
a gene present which encodes a similar ferredoxin to Fdx3
(Table S9†) which, in the case of M. xanthus, is a ferredoxin–
ferredoxin reductase fusion protein. All of these ferredoxins
contain a CXXYXXC(X)nCP iron–sulfur cluster binding motif.
Overall the data suggest that these three genes may form part of
an operon with a similar function across many diﬀerent species.
It is telling that in these bacteria the types of ferredoxins
found in M. marinum are associated with CYP genes. It seems
likely that they are involved in controlling the electron transfer
pathways to enable the monooxygenase enzymes to synthesiseThis journal is © The Royal Society of Chemistry 2018
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View Article Onlinecomplex natural products with a diverse array of biological
function.
Conclusions
Overall we have identied, isolated and characterised unusual
ferredoxins from M. marinum containing [3Fe–4S] clusters
containing proteins. We have used several of them in
conjunction with a ferredoxin reductase to reconstitute the
activity of their associated P450 enzyme. Similar ferredoxins are
co-located with the CYPomes ofMycobacteria, as well as in many
other types of bacteria. We found that the activity of CYP147G1
was reliant on using the physiological ferredoxin and that the
identity of the altered residue of the motif was found to alter the
redox potential. The diversity of these genes in M. marinum
make it an excellent model organism for investigating electron
transfer and its role in bacterial secondary metabolism. The
observation of similar CYP systems in pathogenic bacteria such
as M. ulcerans means these could be targets for drug design
resulting in inhibition. The prevalence of these types of ferre-
doxins across the bacterial kingdom and their presence in the
gene clusters of complex secondary metabolites highlights their
importance in prokaryote secondary metabolism. Further study
will lead to a better understanding of the role of the electron
transfer partner proteins for eﬃcient metabolism and natural
product synthesis which in turn will allow the design of
improved monooxygenase systems for applications in synthetic
biology.
Experimental
Phylogenetic analysis of the P450s and ferredoxins was carried
out using standard methodologies as described in the ESI.† The
cloning, protein purication steps, whole-cell turnovers,
metabolite characterisation and all the aerobic and anaerobic
protein analysis are described in full in the ESI.†
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